Apirox Pharmaceuticals Llp Profile
Key Indicators
- Obligation of Contribution ₹ 7.50 M
as on 15-06-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.30 Cr
as on 15-06-2024
About Apirox Pharmaceuticals Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 7.50 M as per MCA.
- CIN/LLPIN/FCRN
AAU-4771
- Incorporation Date
29 Oct 2020
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Apirox Pharmaceuticals Llp?
Designated Partners(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakeshkumar Ahir  | Designated Partner | 07-Mar-2022 | Current |
| Nagjibhai Ladumor | Designated Partner | 29-Oct-2020 | Current |
| Dhruvesh Ladumor | Designated Partner | 29-Oct-2020 | Current |
| Pinkiben Mevada | Designated Partner | 07-Mar-2022 | Current |
| Jiteshkumar Ahir | Designated Partner | 07-Mar-2022 | Current |
| Jayaben Hadiya | Designated Partner | 07-Mar-2022 | Current |
Financial Performance of Apirox Pharmaceuticals Llp.
Enhance accessibility to Apirox Pharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Apirox Pharmaceuticals Llp?
Unlock access to Apirox Pharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Steuler Industrial Solution (India) Private LimitedActive 5 years 10 monthsMahesh Patel and Bharatkumar Patel are mutual person
Ample Pigments Private LimitedActive 19 years 8 monthsNagjibhai Ladumor and Rakeshkumar Ahir are mutual person
- Saiba Specialty Chemicals Private LimitedActive 4 years 1 month
Mahesh Patel and Bharatkumar Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Feb 2023 | ₹6.30 Cr | Open |
How Many Employees Work at Apirox Pharmaceuticals Llp?
Unlock and access historical data on people associated with Apirox Pharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apirox Pharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apirox Pharmaceuticals Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
